The health economics of bladder cancer: a comprehensive review of the published literature. (Q35642541)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14750899%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

review article

1 reference

title

The health economics of bladder cancer: a comprehensive review of the published literature (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14750899%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14750899%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

3

Alberto Redaelli

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14750899%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

author name string

Marc F Botteman

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14750899%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Benjamin Laskin

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14750899%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Robert Hauser

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14750899%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

language of work or name

1 reference

1 January 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14750899%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14750899%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14750899%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

issue

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14750899%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

page(s)

1315-1330

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14750899%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf03262330

17 November 2019

exact match

0 references

cites work

Current use and questions concerning intravesical bladder cancer group for superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1007%2FBF03262330

The natural history of bladder cancer. Implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03262330

Office evaluation and management of bladder neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03262330

An overview of the treatment of superficial bladder cancer. Intravesical chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03262330

Organ-conserving approaches to muscle-invasive bladder cancer: future alternatives to radical cystectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03262330

Biological markers in superficial bladder tumors and their prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03262330

Sedoanalgesia in urology: a safe, cost-effective alternative to general anaesthesia. A review of 1020 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03262330

Multiple bladder biopsies under intravesical lignocaine anaesthesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03262330

Management of patients with Bacilli Calmette-Guérin-refractory carcinoma in situ of the urinary bladder: cost implications of a clinical trial for valrubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03262330

Bladder papilloma: therapeutic and cost effect of outpatient department management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03262330

Proposal for changes in cystoscopic follow up of patients with bladder cancer and adjuvant intravesical chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03262330

The use of molecular diagnostics in bladder cancer

21 January 2018

1 reference

12 December 2020

Medicare payments from diagnosis to death for elderly cancer patients by stage at diagnosis.

1 reference

12 December 2020

Cigarette smoking, N-acetyltransferase 2 acetylation status, and bladder cancer risk: a case-series meta-analysis of a gene-environment interaction

1 reference

12 December 2020

The diagnosis of neoplasia in patients with asymptomatic microscopic hematuria: a decision analysis

1 reference

12 December 2020

Predictability of recurrent and progressive disease in individual patients with primary superficial bladder cancer.

1 reference

12 December 2020

Routine use of ultrasound and flexible cystoscopy in the control of benign bladder tumours

1 reference

12 December 2020

Cost-effectiveness of investigations for invasive bladder cancer.

1 reference

12 December 2020

Hematuria home screening: repeat testing results

1 reference

12 December 2020

An assessment of the impact of urine cytology screening using a computer-based model of bladder cancer

1 reference

12 December 2020

Contemporary management of superficial bladder cancer

1 reference

12 December 2020

Economics of urinary tract cancers: state of the art.

1 reference

12 December 2020

Cost analysis of neodymium-YAG laser versus transurethral resection treatment of superficial bladder carcinoma.

1 reference

12 December 2020

Current concepts in biomarker technology for bladder cancers

1 reference

12 December 2020

NMP22: a sensitive, cost-effective test in patients at risk for bladder cancer

1 reference

12 December 2020

Mitomycin C reused: an in vitro cost-effectiveness study

1 reference

12 December 2020

Factors affecting recurrence and progression in superficial bladder tumours.

1 reference

12 December 2020

Cost-effectiveness of a modified care protocol substituting bladder tumor markers for cystoscopy for the followup of patients with transitional cell carcinoma of the bladder: a decision analytical approach

1 reference

12 December 2020

Treatment of recurrent bladder surface tumors with laser Nd:Yag: a single-year experience

1 reference

12 December 2020

One-Stage Radical Cystectomy for Bladder Carcinoma: Operative Mortality, Cost/Benefit Analysis

1 reference

12 December 2020

Impact of tumour grade, stage, number and size, smoking habits and sex on the recurrence rate and disease-free interval in patients with transitional cell carcinoma of the bladder.

1 reference

12 December 2020

The use of the bladder-tumour associated analyte test to determine the type of cystoscopy in the follow-up of patients with bladder cancer. The United Kingdom and Eire Bladder Tumour Antigen Study Group

1 reference

12 December 2020

Diagnosis and staging of bladder cancer.

1 reference

12 December 2020

Treatment of superficial bladder tumors: achievements and needs. The EORTC Genitourinary Group

1 reference

12 December 2020

Low dose bacillus Calmette-Guerin for carcinoma in situ of the bladder: long-term results

1 reference

12 December 2020

Intravesical therapy for superficial bladder cancer.

1 reference

12 December 2020

Economics of notification and medical screening for high-risk workers

1 reference

12 December 2020

NMP22 is a sensitive, cost-effective test in patients at risk for bladder cancer

1 reference

12 December 2020

The role of neoadjuvant chemotherapy for invasive bladder cancer

1 reference

12 December 2020

[Outpatient treatment of bladder cancer--lower cost and satisfied patients]

1 reference

12 December 2020

Comparison of molecular and conventional strategies for followup of superficial bladder cancer using decision analysis

1 reference

12 December 2020

The costs of intravesical chemotherapy

1 reference

12 December 2020

Electromotive drug administration of lidocaine as an alternative anesthesia for transurethral surgery.

1 reference

12 December 2020

Neoadjuvant and adjuvant chemotherapy in locally advanced bladder cancer.

1 reference

12 December 2020

Bladder cancer: a review of diagnosis and management

1 reference

12 December 2020

Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study

1 reference

12 December 2020

Epidemiology and etiology of bladder cancer

1 reference

12 December 2020

Cost-effective analysis of pre-cystectomy radioisotope scans

1 reference

12 December 2020

Bladder cancer clinical guidelines panel summary report on the management of nonmuscle invasive bladder cancer (stages Ta, T1 and TIS). The American Urological Association

1 reference

12 December 2020

Economic evaluation of NMP22 in the management of bladder cancer

1 reference

12 December 2020

The agreement among urological experts on the diagnostic management of patients with common urological problems.

1 reference

12 December 2020

Bladder-sparing treatment of invasive bladder cancer

1 reference

12 December 2020

Primary superficial bladder cancer risk groups according to progression, mortality and recurrence.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03262330

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14750899%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

1 reference